Sagimet director George Kemble disposes of 20,206 common shares worth $201,160.97 - SGMT News | RalliesSagimet director George Kemble disposes of 20,206 common shares worth $201,160.97
S
SGMT• Director sale and option exercise
- Sagimet Biosciences director George Kemble sold 20,206 shares of Series A Common Stock on Aug. 11, 2026 at $9.95.
- He exercised stock options for 20,206 shares at $6.36 the same day.
- Direct holdings fell to 62,161 shares following the transactions.
- Remaining stock options totaled 394,050 shares after the exercises.
•
